{"id":469977,"date":"2010-03-25T05:40:41","date_gmt":"2010-03-25T09:40:41","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=70115"},"modified":"2010-03-25T05:40:41","modified_gmt":"2010-03-25T09:40:41","slug":"fda-approves-somaxon-insomnia-pill-torrey-pines-investment-raises-funds-innovation-economy-shows-signs-of-life-more-san-diego-life-sciences-news","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/469977","title":{"rendered":"FDA Approves Somaxon Insomnia Pill, Torrey Pines Investment Raises Funds, Innovation Economy Shows Signs of Life, & More San Diego Life Sciences News"},"content":{"rendered":"\n
Roundup<\/a>, Life Sciences<\/a>, deals<\/a><\/div>\n

\t\tDenise Gellene wrote:<\/strong><\/p>\n

Regulatory and funding headlines dominated a light week. It’s summarized for you here.<\/p>\n

—Torrey Pines Investment<\/b> raised $30 million for a second venture fund <\/a>that aims to raise a total of $150 million. The money will be used to finance acquisitions and development or co-development of drug candidates from pharmaceutical or biotech companies.<\/p>\n

—Connect, a nonprofit group supporting technology and entrepreneurship, reported indications of life <\/a>in San Diego’s innovation economy.<\/b> It found 13 percent more startups were formed in 2009 than in 2008, among other encouraging signs.<\/p>\n

—After two discouraging regulatory delays, Somaxon Pharmaceuticals<\/b> (NASDAQ: SOMX<\/a>) received FDA approval for its insomnia drug<\/a> doxepin (Silenor).<\/p>\n

—Tina Nova, CEO of Carlsbad, CA-based Gentopix<\/b> (NASDAQ: GXDX<\/a>), played to a nearly fully house <\/a>at the Roth Capital Partners Growth Stock Conference in Laguna Niguel, CA. The company specializes in diagnostic services to hematologists and oncologists and was the fifteenth fastest-growing company in the North America last year according to the accounting firm Deloitte.<\/p>\n

—Elcelyx Therapeutics<\/b> raised $1.2 million of a planned $2.2 million equity offering<\/a>. The company’s president is Alain D. Baron, entrepreneur in residence at Morgenthaler Ventures in Menlo Park.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Roundup, Life Sciences, deals Denise Gellene wrote: Regulatory and funding headlines dominated a light week. It’s summarized for you here. —Torrey Pines Investment raised $30 million for a second venture fund that aims to raise a total of $150 million. The money will be used to finance acquisitions and development or co-development of drug candidates […]<\/p>\n","protected":false},"author":2918,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-469977","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/469977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/2918"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=469977"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/469977\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=469977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=469977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=469977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}